Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;48(7):2555-2557.
doi: 10.1016/j.transproceed.2016.07.008.

Acetylsalicylic Acid Resistance After Simultaneous Pancreas-Kidney Transplantation

D Praksch  1 , B Sandor  1 , K K Nagy  2 , M Viola  2 , A Toth  1 , K Toth  1 , P Szakaly  2 , A Varga  3
Affiliations

Acetylsalicylic Acid Resistance After Simultaneous Pancreas-Kidney Transplantation

D Praksch et al. Transplant Proc. 2016 Sep.

Abstract

Background: The most common conditions leading to death after simultaneous pancreas-kidney transplantations (SPKs) are cardiovascular diseases. The aim of this study was to test the platelet aggregation inhibitor acetylsalicylic acid (ASA) resistance in patients after SPKs, including investigations into the triggering factors.

Methods: Thirty-two patients (22 men, 10 women; overall age, 47.4 ± 8.6 years) were involved in our study and took 100 mg ASA per day. We used optical platelet aggregometry to detect resistance.

Results: Resistance occurred in 40.6% of the study group. However, with the use of logistic regression analysis, the examined 24 factors did not show any significant correspondence with resistance.

Conclusions: The incidence of ASA resistance seems to be higher compared with other groups, but the triggering effect is still unproved. Clarifying this question should be important regarding the mortality- and morbidity-reducing capacity of antiplatelet drugs in the management of cardiovascular conditions.

PubMed Disclaimer

LinkOut - more resources